Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Cerebrospinal fluid (CSF) is produced by the choroid plexus and walls of the ventricles in the brain and spinal cord where it is reabsorbed in the venous sinuses. Changes in CSF volume and pressure alter intracranial dynamics such that intracranial hypotension occurs, leading to the potential for intracranial haemorrhage. Increased intracranial pressure can result in irreversible injury to the central nervous system. Among the many functions of the cerebrospinal fluid, it provides protection against acute changes in venous and arterial blood pressure or impact pressure. Nevertheless, trauma, tumors, infections, neurosurgical procedures, and other factors can cause increased intracranial pressure. Both surgical and nonsurgical therapeutic modalities can be used in the management of increased intracranial pressure attributable to traumatic and nontraumatic causes.
The global cerebrospinal fluid management market is witnessing sustainable growth owing to high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures. Moreover, the overall market is also being propelled by rising geriatric population diagnosed with neurological diseases such as Parkinson’s and Alzheimer’s disease, growing demand for minimally invasive surgeries, and high funding by private organizations. Furthermore, rising joint venture and cross-industry collaboration activities would further provide significant growth opportunities to this market in the future. However, the global cerebrospinal fluid management market is hindered by dearth of trained professionals and complications related to CSF shunts.
The report analyses the global cerebrospinal fluid management market based on product, end user and geography.
Based on product, the cerebrospinal fluid management market is segmented into shunts and external drainage systems. The shunts are further categorized into ventriculoperitoneal (VP), ventriculoatrial (VA), lumboperitoneal (LP) and ventriculopleural (VPL) shunts. Whereas, the external drainage systems are external ventricular drainage (EVD) systems and lumbar drainage (LD) systems. The placement of cerebral spinal fluid (CSF) shunt systems to treat hydrocephalus is a common medical procedure and a life-saving treatment for many patients. These shunt systems drain excess fluid from the brain to another part of the body where the fluid is absorbed as part of the circulatory process.
Based on end user, this market is categorized into paediatric, adult and geriatric. Cerebrospinal fluid shunt infection is one of the most common and serious complications of CSF shunt therapy in adults and paediatrics. Supplementation of antibiotic treatment with partial (externalization) or with complete shunt hardware removal is an option in the management of CSF shunt infection.
By geography, the global cerebrospinal fluid management market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world regions which includes Latin America, and Middle East & Africa. North America accounted for the market largest share in 2018, owing to rising prevalence of hydrocephalus and increasing funding for hydrocephalus research in the US. Countries such as China and Japan are witnessing substantial growth in the cerebrospinal fluid management market. Increasing activities for expansion is likely to boost the market in the future. In addition to this, Asia Pacific is projected to grow at a lucrative growth rate over the estimate period. Increasing per capita expenditure and prevalence of neurological diseases are the key growth drivers for cerebrospinal fluid management in this region.
The leading market players of the global cerebrospinal fluid management market include Medtronic PLC, Integra Lifesciences Holdings Corporation, B. Braun Melsungen, Spiegelberg GmbH & Co. Kg, SOPHYSA (TKB Group), Natus Medical Incorporated, Dispomedica GmbH, Deltasurgical, Argi Grup, Moller Medical GmbH and Wellong Instruments Co., Ltd.
The global cerebrospinal fluid management market is segmented based on product, end user and geography. Based on product, the market is segmented into shunts and external drainage systems. The shunts are further categorized into ventriculoperitoneal (VP), ventriculoatrial (VA), lumboperitoneal (LP) and ventriculopleural (VPL) shunts. Whereas, the external drainage systems are external ventricular drainage (EVD) systems and lumbar drainage (LD) systems.
Based on end user, this market is categorized into paediatric, adult and geriatric. Cerebrospinal fluid shunt infection is one of the most common and serious complications of CSF shunt therapy in adults and paediatrics.
By geography, the global cerebrospinal fluid management market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world regions which includes Latin America, and Middle East & Africa. North America accounted for the market largest share in 2018, owing to rising prevalence of hydrocephalus and increasing funding for hydrocephalus research in the US.
Why to buy this report:
